CSDB 3.0

CSDB 3.0
Product Description

The serialisation solution must integrate production lines, partners, customers & suppliers - this means comprehensive integration, adaptation of processes and high security measures. Whether at the intersections between ERP software and production and packaging machines, to the systems of external service providers or to national verification systems: The serialisation of medicines requires technical expertise, process know-how and the software solution Arvato CSDB, which reliably controls the entire serialisation process.

Read more Show less

Arvato Systems

  • DE
  • 2023
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
IT/Software solution provider
Primary activities
Technology
View company profile
Categories
more categories Show less
Specifications
  • Details
    Generation and management of serial numbers. Data exchange between all relevant systems. Creation of interfaces for production lines. Connecting customers, suppliers and production sites. Data recording in national verification systems worldwide, including reporting – whether in China, the USA or Europe. Adjustment of serial number data formats in accordance with applicable guidelines in the respective countries. Incorporation of ERP systems as needed
  • Selling Points
    Experienced Technicians; Extensive IT expertise, a high level of technical understanding, strong industry knowledge, and partnership in action - that's Arvato Systems. As a team, we develop innovative IT solutions, bring our customers into the cloud, integrate digital processes, and take over the operation and support of IT systems. This is how we create the basis for your Digital Transformation.
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

Arvato Systems

  • DE
  • 2023
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
IT/Software solution provider
Primary activities
Technology
View company profile

More Products from Arvato Systems (2)

  • NMVS

    Product NMVS

    Arvato Systems has been officially named as National Blueprint Service Provider by the European Medicines Verification Organization (EMVO).

    In addition, as part of its comprehensive supplier evaluation, the EMVO has confirmed Arvato Systems' quality standards. All member states of the ...
  • platbricks®

    Product platbricks®

    Digitizing business processes end-to-end, avoiding isolated solutions, preventing complexity and staying within budget? Not that easy! What do you need to eliminate the "not"? A platform with standard interfaces to ERP/WMS systems, a control center with real-time capability, expandable process logic and co...

Arvato Systems resources (4)

  • 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures

    News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures

    The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. 
    9 Jan 2024
  • 2024 Pharma Trends Outlook: Collaboration, Market Maturity, and Digital Futures 

    Whitepaper 2024 Pharma Trends Outlook: Collaboration, Market Maturity, and Digital Futures 

    Our annual Pharma Trends Outlook report delves into the critical challenges facing the pharmaceutical supply chain in 2024. From protecting against supply shortages, quality management maturity, and cross-industry collaboration for sustainability and patient-centred initiatives, the pharmaceutical industry must contend with the increasing need to digitise operations with generative AI and machine-learning technologies, or risk being left behind in a changing world. In partnership with Arvato Systems, the CPHI Online 2024 Pharma Trends Outlook dissects emerging trends for 2024 with expert insight providing valuable perspectives on the rapidly changing pharmaceutical landscape. 12 Pharma Trends for 2024 Supply chain digitisation with generative AI Pharmaceutical packaging innovations Quality Management Maturity Emerging biotech and R&D outsourcing trends Collaboration for sustainability goals Excipient development and manufacturing Balancing drug pricing, manufacturing costs, and patient access Science-backed evidence for herbal medicines Accelerating B2B pharma marketing Alzheimer's research What 2023 drug approvals mean for 2024 An emerging Market: Middle East, Saudi Arabia, and beyond
  • Arvato Systems Joins Bundesverband Der Arzneimittel-Hersteller e.v. (German Association of Pharmaceutical Manufacturers)

    News Arvato Systems Joins Bundesverband Der Arzneimittel-Hersteller e.v. (German Association of Pharmaceutical Manufacturers)

    Arvato Systems is a new member of the German Association of Pharmaceutical Manufacturers (BAH). The BAH is considered the strongest trade association in Germany's pharmaceutical industry in terms of membership. As a provider of digital solutions in the pharmaceutical industry, Arvato Systems will now also be involved in the BAH's large partner network.
    1 Dec 2023
  • Succesful Strategies against Counterfeiting in the Pharma and Chemical Industry

    Technical Data Succesful Strategies against Counterfeiting in the Pharma and Chemical Industry

    Product counterfeiting is a common and not a small problem. This is increasingly noticeable in the pharmaceutical, chemical, and medical devices sectors. To counteract this, track & trace solutions and brand protection communication are highly important. This enables companies to respond quickly and effectively to product piracy and thus not only protect their product but also save lives.

    The brand protection study published by Arvato Systems together with Karg and Petersen once again underlines the importance of anti-piracy measures in all industries. The following sheet provides a detailed insight into the results for the industries of pharmaceutical, chemical, and medical devices.